HIV researcher David Alain Wohl, MD, urges AIDS activists to be a vanguard against indifference, overreach and shortsightedness.

Writer Anna Forbes responds to an open letter by HIV researcher David Alain Wohl, MD, that urges AIDS activists to do more.

A tablet containing bictegravir and the contents of Descovy suppressed HIV as well as boosted protease inhibitor regimens.

The controversial head of the AIDS Healthcare Foundation has taken his PrEP-skepticism campaign to the prestigious medical journal AIDS.

HIV scientists and advocates are waging a powerful war against the global epidemic.

The social media buzz on the annual HIV science conference.

Truvada metabolizes differently in the vagina than in the rectum, leaving less room for error in protecting vaginal tissues from HIV.

Not sticking to the daily HIV medication regimen is also associated with increased health care costs.

People treated with VRC01 maintained undetectable viral load for up to 42 weeks after stopping antiretroviral therapy.

A survey of transgender women found such concerns led many to take their hormones or HIV meds not as prescribed.